Shanghai Pharmaceuticals Holding Co Ltd 2020 SR
The report highlights Shanghai Pharma's entry into the Fortune Global 500 and its significant contributions to COVID-19 anti-epidemic efforts in 2020. It details the company's R&D investments, including progress in innovative drug pipelines and the commencement of the SPH Biological Medicine Industry Base. The report also emphasizes its role as a leading importer of drugs and vaccines in China, its commitment to poverty alleviation in Midu County, and its comprehensive environmental management strategies, including the recognition of five 'Green Factories'.
Company: Shanghai Pharmaceuticals Holding Co Ltd
Sector: Manufacturing
Country: China
Year: 2020
Type: SR
Pages: 138
Back to company
Shanghai Pharmaceuticals Holding Co Ltd
Corporate Social Responsibility Report
The report highlights Shanghai Pharma's entry into the Fortune Global 500 and its significant contributions to COVID-19 anti-epidemic efforts in 2020. It details the company's R&D investments, including progress in innovative drug pipelines and the commencement of the SPH Biological Medicine Industry Base. The report also emphasizes its role as a leading importer of drugs and vaccines in China, its commitment to poverty alleviation in Midu County, and its comprehensive environmental management strategies, including the recognition of five 'Green Factories'.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Type
Sustainability Report
Language
English, Chinese
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Workplace Fatalities
Employees